BACKGROUND: Metabolic syndrome (MetS) and functional limitation have been linked, but whether and how specific components of MetS and associated factors, such as inflammation, drive this relationship is unknown. METHODS: Data are from 2,822 men and women, aged 70-79 years, participating in the Health, Aging, and Body Composition (Health ABC) study and followed for 5 years. Presence of MetS at baseline was defined according to the National Cholesterol Education Program Adult Treatment Panel III guidelines. Interleukin-6, C-reactive protein, and body fat mass were measured at baseline. Measures of physical performance, including 400-m walk time, 20-m walking speed, and the Health ABC physical performance battery (PPB) were obtained at baseline and examination years 2, 4, and 6. RESULTS: A total of 1,036 (37%) individuals met criteria for MetS. MetS was associated with poorer physical performance at baseline. Effect estimates between MetS and gait speed, and components of the Health ABC PPB (standing balance and repeated sit-to-stand performance) were modestly attenuated after adjustment for inflammation. All associations were attenuated to nonsignificance after adding total body fat mass to the model. Longitudinal analyses yielded similar results. Individual MetS component analysis revealed that abdominal obesity explained the largest fraction of the variation in physical performance. CONCLUSIONS: Although inflammatory biomarkers partially accounted for the relationship between MetS and aspects of physical performance, overall findings implicate adiposity as the primary factor explaining poorer physical performance in older adults with MetS.
BACKGROUND:Metabolic syndrome (MetS) and functional limitation have been linked, but whether and how specific components of MetS and associated factors, such as inflammation, drive this relationship is unknown. METHODS: Data are from 2,822 men and women, aged 70-79 years, participating in the Health, Aging, and Body Composition (Health ABC) study and followed for 5 years. Presence of MetS at baseline was defined according to the National Cholesterol Education Program Adult Treatment Panel III guidelines. Interleukin-6, C-reactive protein, and body fat mass were measured at baseline. Measures of physical performance, including 400-m walk time, 20-m walking speed, and the Health ABC physical performance battery (PPB) were obtained at baseline and examination years 2, 4, and 6. RESULTS: A total of 1,036 (37%) individuals met criteria for MetS. MetS was associated with poorer physical performance at baseline. Effect estimates between MetS and gait speed, and components of the Health ABC PPB (standing balance and repeated sit-to-stand performance) were modestly attenuated after adjustment for inflammation. All associations were attenuated to nonsignificance after adding total body fat mass to the model. Longitudinal analyses yielded similar results. Individual MetS component analysis revealed that abdominal obesity explained the largest fraction of the variation in physical performance. CONCLUSIONS: Although inflammatory biomarkers partially accounted for the relationship between MetS and aspects of physical performance, overall findings implicate adiposity as the primary factor explaining poorer physical performance in older adults with MetS.
Authors: Martin K Rutter; James B Meigs; Lisa M Sullivan; Ralph B D'Agostino; Peter W F Wilson Journal: Circulation Date: 2004-07-19 Impact factor: 29.690
Authors: Aruna D Pradhan; Nancy R Cook; Julie E Buring; JoAnn E Manson; Paul M Ridker Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-06 Impact factor: 8.311
Authors: Matteo Cesari; Brenda W J H Penninx; Marco Pahor; Fulvio Lauretani; Anna Maria Corsi; G Rhys Williams; Jack M Guralnik; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2004-03 Impact factor: 6.053
Authors: Anda Botoseneanu; Walter T Ambrosius; Daniel P Beavers; Nathalie de Rekeneire; Stephen Anton; Timothy Church; Sara C Folta; Bret H Goodpaster; Abby C King; Barbara J Nicklas; Bonnie Spring; Xuewen Wang; Thomas M Gill Journal: J Am Geriatr Soc Date: 2015-01-30 Impact factor: 5.562
Authors: Matthew J Peterson; Dana K Thompson; Carl F Pieper; Miriam C Morey; Virginia B Kraus; William E Kraus; Patrick Sullivan; Gerda Fillenbaum; Harvey J Cohen Journal: J Gerontol A Biol Sci Med Sci Date: 2015-03-05 Impact factor: 6.053
Authors: A W Frank; J P Farthing; P D Chilibeck; C M Arnold; W P Olszynski; S A Kontulainen Journal: J Nutr Health Aging Date: 2015-01 Impact factor: 4.075
Authors: Anda Botoseneanu; Haiying Chen; Walter T Ambrosius; Heather G Allore; Stephen Anton; Sara C Folta; Abby C King; Barbara J Nicklas; Bonnie J Spring; Elsa S Strotmeyer; Thomas M Gill Journal: J Am Geriatr Soc Date: 2017-03-28 Impact factor: 5.562
Authors: Joshua Z Willey; Yeseon P Moon; Erin R Kulick; Ying Kuen Cheung; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind Journal: Neuroepidemiology Date: 2017-08-16 Impact factor: 3.282
Authors: Rohit Ramanathan; Anita Kohli; María Clara Ingaramo; Alka Jain; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko Journal: J Gerontol A Biol Sci Med Sci Date: 2013-03-22 Impact factor: 6.053
Authors: Zsuzsanna Tucsek; Peter Toth; Stefano Tarantini; Danuta Sosnowska; Tripti Gautam; Junie P Warrington; Cory B Giles; Jonathan D Wren; Akos Koller; Praveen Ballabh; William E Sonntag; Zoltan Ungvari; Anna Csiszar Journal: J Gerontol A Biol Sci Med Sci Date: 2014-06-03 Impact factor: 6.053